Kiniksa Pharmaceuticals International PLC (KNSA)
21.06
-0.11
(-0.52%)
USD |
NASDAQ |
Dec 04, 13:59
Kiniksa Pharmaceuticals International Price to Book Value: 3.480 for Dec. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 3.498 |
| December 02, 2024 | 3.61 |
| November 29, 2024 | 3.648 |
| November 27, 2024 | 3.688 |
| November 26, 2024 | 3.641 |
| November 25, 2024 | 3.602 |
| November 22, 2024 | 3.516 |
| November 21, 2024 | 3.484 |
| November 20, 2024 | 3.504 |
| November 19, 2024 | 3.440 |
| November 18, 2024 | 3.552 |
| November 15, 2024 | 3.518 |
| November 14, 2024 | 3.603 |
| November 13, 2024 | 3.737 |
| November 12, 2024 | 3.798 |
| November 11, 2024 | 3.807 |
| November 08, 2024 | 3.777 |
| November 07, 2024 | 3.802 |
| November 06, 2024 | 3.805 |
| November 05, 2024 | 3.640 |
| November 04, 2024 | 3.549 |
| November 01, 2024 | 3.713 |
| October 31, 2024 | 3.732 |
| October 30, 2024 | 3.802 |
| October 29, 2024 | 3.844 |
| Date | Value |
|---|---|
| October 28, 2024 | 4.558 |
| October 25, 2024 | 4.534 |
| October 24, 2024 | 4.445 |
| October 23, 2024 | 4.432 |
| October 22, 2024 | 4.424 |
| October 21, 2024 | 4.274 |
| October 18, 2024 | 4.336 |
| October 17, 2024 | 4.417 |
| October 16, 2024 | 4.346 |
| October 15, 2024 | 4.468 |
| October 14, 2024 | 4.397 |
| October 11, 2024 | 4.386 |
| October 10, 2024 | 4.209 |
| October 09, 2024 | 4.116 |
| October 08, 2024 | 4.040 |
| October 07, 2024 | 3.918 |
| October 04, 2024 | 4.042 |
| October 03, 2024 | 4.011 |
| October 02, 2024 | 4.050 |
| October 01, 2024 | 4.206 |
| September 30, 2024 | 4.126 |
| September 27, 2024 | 4.094 |
| September 26, 2024 | 3.923 |
| September 25, 2024 | 3.946 |
| September 24, 2024 | 4.004 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.869
Minimum
Apr 05 2023
7.404
Maximum
Jun 29 2020
3.690
Average
3.600
Median
Mar 11 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.548 |
| NovaBay Pharmaceuticals Inc | 2.750 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.361 |
| Theriva Biologics Inc | 0.1491 |
Price to Book Value Related Metrics
| PS Ratio | 3.992 |
| PEG Ratio | -5.516 |
| Price to Free Cash Flow | 138.07 |
| Price | 21.06 |
| Earnings Yield | -0.66% |
| Market Cap | 1.521B |
| PEGY Ratio | -5.516 |